Does patient and public involvement impact public health decision-making? A 10 year retrospective analysis of public consultation in Brazil

Table 1 Characteristics of the technology incorporation processes into the SUS between 2012 and 2021

Characteristics	N (%)
Type of technology
Medicines	366 (76)
Procedures	80 (17)
Products	33 (7)
Demander
Government	262 (55)
Private sector	184 (38)
Social	17 (4)
Mixed	16 (3)
Indication
Neoplasms	66 (14)
Infectious and parasitic diseases	66 (14)
Endocrine, nutritional and metabolic diseases	59 (13)
Diseases of the musculoskeletal system and connective tissue	52 (11)
Diseases of the nervous system	39 (8)
Diseases of the circulatory system	26 (6)
Diseases of the respiratory system	25 (5)
Others	136 (29)
Final decision in question
In favour of adopting the technology	264 (55)
Against the adoption of the technology	215 (45)

Others: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (5%); factors influencing health status and contact with health services (4%); diseases of the digestive system (3%); diseases of the skin and subcutaneous tissue (3%); symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (3%); diseases of the eye and adnexa (2%); mental and behavioural disorders (2%); diseases of the genitourinary system (2%); injury, poisoning and certain other consequences of external causes (1%); diseases of the ear and mastoid process (1%); pregnancy, childbirth and the puerperium (1%)

ISSN: 1478-4505